Medical News

RSS

Feeding regimens may improve respiratory health in premature babies with lung disease

Improving lung function in premature babies with a severe lung disease may be linked to their feeding regimen, according to a new University of Michigan study.

27 Jan 2011

Nexstim closes additional equity financing for approximately EUR 11.4 million

Nexstim Oy, a medical device company commercializing noninvasive brain diagnostic and therapy technologies, today announced that it has closed on additional equity financing of approximately EUR 11.4 million.

27 Jan 2011

WSJ: Biotech generics battle heats up

A battle is heating up over the meaning of a single word in the health overhaul that could mean billions of dollars to the makers of biotechnology drugs (Mundy, 1/26).

27 Jan 2011

Six key points to tackle substance abuse, addiction problems among nurses

As many as ten to 20 per cent of nurses and nursing students may have substance abuse and addiction problems, but the key to tackling this difficult issue - and protecting public safety - is support and treatment, not punishment. That is the key message in a paper in the February issue of the Journal of Clinical Nursing.

27 Jan 2011

CyDex stockholders approve merger with Ligand

CyDex Pharmaceuticals, Inc. today announced that its stockholders have voted to approve an Agreement and Plan of Merger between CyDex and Ligand Pharmaceuticals Incorporated and that closing of the transaction has taken place. CyDex will continue its business operations, based in Lenexa, Kansas, as a wholly owned subsidiary of Ligand.

27 Jan 2011

Anapharm Europe, PharmaNet officially terminate joint venture

PharmaNet Development Group, and Anapharm Europe, S.L., both leading providers of drug development services to the pharmaceutical, biotechnology, generic drug and medical device industries, announced that their joint venture for the collaborative provision of bioanalytical services officially ended December 22, 2010.

27 Jan 2011

Impulse Monitoring signs agreement with MidMichigan Health

Impulse Monitoring, a leading provider of intraoperative neurophysiological monitoring services to hospitals, today announced that it has signed an agreement with MidMichigan Health, Midland, MI.

26 Jan 2011

Teva, APP enter agreement for launch of generic Gemzar

Teva Pharmaceutical Industries Ltd. and APP Pharmaceuticals, Inc. announced today the commercial launch of Gemcitabine HCI for Injection in 200 mg and 1 g single dose vials, the generic version of Gemzar®, in the United States, pursuant to a commercialization, manufacture and supply agreement signed by the two companies.

26 Jan 2011

Viewpoints: Trying to regulate insurance premium rates, fighting Medicare fraud

Big, powerful industries facing tougher government oversight — the health insurance industry, say — know that the legislative battle in Congress or state capitals is just the first skirmish. The more important fight is over the regulations that implement legislative policies (Michael Hiltzik, 1/25).

26 Jan 2011

Medica Health Plans grants $6.5 million to Research Institute

The Medica Research Institute has received a contribution from Medica Health Plans in the amount of $6.5 million. This contribution will be used by the Research Institute to further its mission.

26 Jan 2011

LDR announces submission of Mobi-C cervical artificial disc PMA to FDA

LDR, a privately held medical device company offering innovative spinal implants for both non-fusion and fusion applications, announced the January 14th submission of its single-level Mobi-C cervical artificial disc PMA to the FDA.

26 Jan 2011

Lehigh Valley Physician Hospital, Aetna reach agreement on new four-year contract for LVHN

Aetna announced that it has reached agreement on a new four-year contract for Lehigh Valley Health Network with Lehigh Valley Physician Hospital, DBA Valley Preferred.

26 Jan 2011

Study: Low SES is linked to high risk of depression in patients with RA

Physical and Mental Health Disparities Found in Those with Low Socioeconomic Position. A recent study confirmed that low socioeconomic status is associated with higher risk of depressive symptoms in patients with rheumatoid arthritis.

26 Jan 2011

ICV Partners acquires Stauber Performance Ingredients

ICV Partners, a private investment firm focused on investments in smaller middle market companies, announced today the acquisition of Stauber Performance Ingredients, Inc., a value-added distributor of nutraceutical ingredients to the dietary supplement industry, from J. H. Whitney & Co.

26 Jan 2011

ChemoCentryx commences CCX832 Phase I trial in patients with psoriasis

ChemoCentryx, today announced the initiation of a Phase I clinical trial of CCX832, an orally-administered small molecule that is a potent and selective inhibitor of the chemoattractant receptor, ChemR23.

26 Jan 2011

First Edition: January 26, 2011

Reporting for KHN, in collaboration with Politico, Bara Vaida writes: "Lobbyists for doctors, hospitals and drug companies are urging lawmakers to derail a planned government panel that health industry officials fear will sharply curb Medicare spending -- a critical revenue source for them".

26 Jan 2011

Anadys begins dosing in ANA598 Phase IIb study for hepatitis C

Anadys Pharmaceuticals, announced today that dosing has begun in the Phase IIb study of ANA598 in combination with pegylated interferon and ribavirin in hepatitis C patients.

26 Jan 2011

Researchers develop anti-HIV gene therapy for rendering T-cells resistant to infection

An innovative genetic strategy for rendering T-cells resistant to HIV infection without affecting their normal growth and activity is described in a paper published in Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc. The paper is available free online.

26 Jan 2011

Ligand announces acquisition of CyDex Pharmaceuticals

Ligand Pharmaceuticals Incorporated today announced it has acquired privately held CyDex Pharmaceuticals, for a combination of cash and contingent payments.

26 Jan 2011

Next generation sequencing on the European growth path: Report

Next Generation Sequencers have found their way into service providing labs and the global biomedical research community. 2010 has seen a serious uptake of Next Generation Sequencing technology, and today it is perceived as an indispensable tool.

26 Jan 2011